ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ
$17.70−$0.1300 (−0.73%) on the dayAs of the close; data may be delayed.
ADRX price, last 12 months
Key stats
- Previous close
- $17.83
- Open
- $17.75
- Day range
- $17.50 – $18.33
- 52-week range
- $16.64 – $23.21
- Volume
- 283.4K
- Avg volume (20 days)
- —
- Market cap
- $1.9B
Performance
1W+2.8%
1M—
3M—
6M—
YTD—
1Y—
About ADARx Pharmaceuticals, Inc.
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
- Listed on
- NASDAQ
- Market cap
- $1.9B